NPPA issued the retail price for the Moxifloxacin Hydrochloride IPeq. to Moxifloxacin 0.5% w/v Dexamethasone Sodium Phosphate IP Eq. to Dexamethasone Phosphate 0.1% w/v Benzalkonium Chloride Solution IP 0.01% v/v(As Preservative)’ for M/s Skymap Pharmaceuticals Pvt. Ltd (Manufacturer) & M/s Wellgen Medicare LLP (Marketer)

Sep 15, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on September 09, 2026, issued the retail price for the Moxifloxacin Hydrochloride IPeq. to Moxifloxacin 0.5% w/v Dexamethasone Sodium Phosphate IP Eq. to Dexamethasone Phosphate 0.1% w/v Benzalkonium Chloride Solution IP 0.01% v/v(As Preservative)’ for M/s Skymap Pharmaceuticals Pvt. Ltd (Manufacturer) & M/s Wellgen Medicare LLP (Marketer).

The following have been stated:

• The retail price for the Each ml contains:Moxifloxacin Hydrochloride IPeq. to Moxifloxacin 0.5% w/vDexamethasone Sodium Phosphate IP Eq. to Dexamethasone Phosphate 0.1% w/v Benzalkonium Chloride Solution IP 0.01% v/v(As Preservative)’ for M/s Skymap Pharmaceuticals Pvt. Ltd (Manufacturer) & M/s Wellgen Medicare LLP (Marketer) will be Rs. 20.4/-.

• Sum of MAT value considered for price calculation (in Lakhs) - 2,761.72 

• Sum of PTR per unit considered for price calculation - 211.03

[Notification No. 19(5313)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT